RSNA 2010 

Abstract Archives of the RSNA, 2010


SSE17-02

Prediction of Periprocedural Ischemic Complication in Carotid Artery Stenting with Filter Embolic Protection Device (Angioguard XP): Feasibility of Magnetic Resonance (MR) Plaque Imaging—Single Center Study

Scientific Formal (Paper) Presentations

Presented on November 29, 2010
Presented as part of SSE17: Neuroradiology (Interventional)

Participants

Katsutoshi Takayama MD, Presenter: Nothing to Disclose
Kaoru Myouchin MD, Abstract Co-Author: Nothing to Disclose
Hiroyuki Nakagawa MD, Abstract Co-Author: Nothing to Disclose
Toshiaki Taoka MD, Abstract Co-Author: Nothing to Disclose
Takeshi Wada MD, Abstract Co-Author: Nothing to Disclose
Masahiko Sakamoto, Abstract Co-Author: Nothing to Disclose
Kimihiko Kichikawa MD, Abstract Co-Author: Nothing to Disclose
Shinichiro Kurokawa, Abstract Co-Author: Nothing to Disclose

PURPOSE

Our purpose is to investigate the feasibility of magnetic resonance (MR) plaque imaging to predict the high risk lesion for ischemic complication during carotid artery stenting (CAS) using filter embolic protection device (EPD).

METHOD AND MATERIALS

Seventy five carotid artery stenotic lesions in 70 patients before CAS (62 male and eight female; median age, 72.2 years) were evaluated by MR plaque imaging with black blood T1 weighted images. The population consisted of 45.3 % symptomatic stenosis more than 50% at the common or internal carotid artery (ICA), and 54.7 % asymptomatic stenosis more than 80% stenosis. All CAS procedures were performed by standard procedure using filter EPD (Angioguard XP). Main plaque components were classified into unstable plaque (intraplaque hemorrhage and lipid-rich/necrotic core) and stable (fibrous tissue and dense calcification) from the signal pattern. Development of new ischemic lesions on diffusion-weighted imaging (DWI) was assessed within 48 hours after CAS. We made statistical assessment on the plaque classification and the number of new ischemic lesions.

RESULTS

Technical success with the CAS procedures was achieved in 75(100%) of 75 procedures. Ipsilateral new ischemic lesions were observed in 25 CAS procedures (33.3%). Ipsilateral multiple ischemic lesions (>10) were observed in seven CAS procedures (6.7%). In 5 patients with multiple ischemic lesions, 2 showed minor strokes, 2 showed TIA, and 1 was asymtopmatic. New ischemic lesions except multiple ischemic lesions were all asymtopmatic. There was no significant difference between unstable and stable plaque about the presence of new ischemic lesion. However, multiple ischemic lesions occurred significantly (P < 0.01) more frequently in patients with unstable plaque.

CONCLUSION

Presence of unstable carotid plaques showed a higher risk of ischemic complication of CAS with filter EPD than stable plaques.

CLINICAL RELEVANCE/APPLICATION

MR plaque imaging can demostrate high risk lesion of precedual ischemic complication of carotid artery stetning and is recommended as part of a MR study prior to carotid artery stenting.

Cite This Abstract

Takayama, K, Myouchin, K, Nakagawa, H, Taoka, T, Wada, T, Sakamoto, M, Kichikawa, K, Kurokawa, S, Prediction of Periprocedural Ischemic Complication in Carotid Artery Stenting with Filter Embolic Protection Device (Angioguard XP): Feasibility of Magnetic Resonance (MR) Plaque Imaging—Single Center Study.  Radiological Society of North America 2010 Scientific Assembly and Annual Meeting, November 28 - December 3, 2010 ,Chicago IL. http://archive.rsna.org/2010/9007367.html